Form 4 Tracker
Acumen Pharmaceuticals, Inc.
ABOS

26 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 21, 2026Jan 23 11:12 PMEric SiemersChief Medical Officer
Sale
2,331$1.80$4.2K256,266(D)

View →

Jan 22, 2026Jan 23 11:11 PMMatt ZugaCFO & Chief Business Officer
Sale
1,687$1.86$3.1K304,924(D)

View →

Jan 21, 2026Jan 23 11:11 PMMatt ZugaCFO & Chief Business Officer
Sale
2,473$1.81$4.5K306,611(D)

View →

Jan 22, 2026Jan 23 11:10 PMDaniel Joseph OconnellDirector, Chief Executive Officer
Sale
2,689$1.88$5.1K881,275(D)

View →

Jan 21, 2026Jan 23 11:10 PMDaniel Joseph OconnellDirector, Chief Executive Officer
Sale
9,346$1.81$16.9K883,964(D)

View →

Jan 22, 2026Jan 23 11:10 PMRussell BartonChief Operating Officer
Sale
462$1.84$850205,092(D)

View →

Jan 21, 2026Jan 23 11:10 PMRussell BartonChief Operating Officer
Sale
2,315$1.81$4.2K205,554(D)

View →

Jan 23, 2026Jan 23 9:01 PMMeisner Derek M
Proposed Sale
5,633$1.86$10.5K

View →

Jan 22, 2026Jan 22 9:16 PMMeisner Derek M
Proposed Sale
1,054$1.84$1.9K

View →

Jan 22, 2026Jan 22 9:16 PMSiemers Eric
Proposed Sale
895$1.82$1.6K

View →

Jan 22, 2026Jan 22 9:15 PMBarton Russell
Proposed Sale
462$1.84$850

View →

Jan 22, 2026Jan 22 9:14 PMZuga Matt
Proposed Sale
1,687$1.86$3.1K

View →

Jan 22, 2026Jan 22 9:13 PMOConnell Daniel Joseph
Proposed Sale
2,689$1.88$5.1K

View →

Jan 21, 2026Jan 21 9:46 PMMeisner Derek M
Proposed Sale
2,247$1.81$4.1K

View →

Jan 21, 2026Jan 21 9:44 PMSiemers Eric
Proposed Sale
2,331$1.80$4.2K

View →

Jan 21, 2026Jan 21 9:37 PMBarton Russell
Proposed Sale
2,315$1.81$4.2K

View →

Jan 21, 2026Jan 21 9:34 PMZuga Matt
Proposed Sale
2,473$1.81$4.5K

View →

Jan 21, 2026Jan 21 9:30 PMOConnell Daniel Joseph
Proposed Sale
9,346$1.81$16.9K

View →

Jan 12, 2026Jan 12 9:03 PMMeisner Derek M
Proposed Sale
8,548$1.71$14.7K

View →

Jan 12, 2026Jan 12 9:02 PMOConnell Daniel Joseph
Proposed Sale
5,388$1.73$9.3K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 16, 2026Jan 21 11:29 PMJames J. DohertyPresident and CDO
Grant/Award
250,300$1.89250,300(D)

View →

← Previous

Page 2 of 2